Profilo
William Earnest Pullman is currently a Director at Proximagen Group Plc and a Director at USL Pharma International UK Ltd. He previously worked as the Chief Medical Officer & Senior Vice President at Cubist Pharmaceuticals LLC, the Chief Development Officer & Executive VP at Dyax Corp., and the Senior Vice President-Exploratory Development at TransForm Pharmaceuticals, Inc. Pullman holds a doctorate degree from both the Australian National University and The University of Western Australia.
Posizioni attive di William Earnest Pullman
| Società | Posizione | Inizio |
|---|---|---|
USL Pharma International UK Ltd.
USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops drugs for the treatment of neurological and inflammatory disorders | Direttore/Membro del Consiglio | 18/12/2013 |
Proximagen Group Ltd.
Proximagen Group Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics designed for the treatment of central nervous system diseases | Direttore/Membro del Consiglio | 18/12/2013 |
Precedenti posizioni note di William Earnest Pullman
| Società | Posizione | Fine |
|---|---|---|
| DYAX CORP. | Direttore Tecnico/Scientifico/R&S | - |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | - |
| CUBIST PHARMACEUTICALS INC | Direttore Tecnico/Scientifico/R&S | - |
Formazione di William Earnest Pullman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Dyax Corp.
Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Proximagen Group Ltd.
Proximagen Group Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics designed for the treatment of central nervous system diseases | Health Technology |
Australian National University
Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USL Pharma International UK Ltd.
USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops drugs for the treatment of neurological and inflammatory disorders | Health Technology |
















